37 related articles for article (PubMed ID: 28662884)
1. Predictors of delayed sputum smear conversion among pulmonary tuberculosis patients in Kota Kinabalu, Malaysia: A retrospective cohort study.
Mokti K; Md Isa Z; Sharip J; Abu Bakar SN; Atil A; Hayati F; Syed Abdul Rahim SS
Medicine (Baltimore); 2021 Aug; 100(31):e26841. PubMed ID: 34397855
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcome of new smear positive pulmonary tuberculosis patients in Penang, Malaysia.
Atif M; Sulaiman SA; Shafie AA; Ali I; Asif M; Babar ZU
BMC Infect Dis; 2014 Jul; 14():399. PubMed ID: 25037452
[TBL] [Abstract][Full Text] [Related]
3. Impact of smoking on sputum culture conversion and pulmonary tuberculosis treatment outcomes in Brazil: a retrospective cohort study.
Cailleaux-Cezar M; Loredo C; Silva JRLE; Conde MB
J Bras Pneumol; 2018 Apr; 44(2):99-105. PubMed ID: 29791542
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis and excess alcohol use in the United States, 1997-2012.
Volkmann T; Moonan PK; Miramontes R; Oeltmann JE
Int J Tuberc Lung Dis; 2015 Jan; 19(1):111-9. PubMed ID: 25519800
[TBL] [Abstract][Full Text] [Related]
5. Male Sex Is Associated With Worse Microbiological and Clinical Outcomes Following Tuberculosis Treatment: A Retrospective Cohort Study, a Systematic Review of the Literature, and Meta-analysis.
Chidambaram V; Tun NL; Majella MG; Ruelas Castillo J; Ayeh SK; Kumar A; Neupane P; Sivakumar RK; Win EP; Abbey EJ; Wang S; Zimmerman A; Blanck J; Gupte A; Wang JY; Karakousis PC
Clin Infect Dis; 2021 Nov; 73(9):1580-1588. PubMed ID: 34100919
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of time to sputum smear conversion and its association with treatment outcomes among drug-resistant tuberculosis patients: a retrospective record-reviewing study.
Alzarea AI; Saifullah A; Khan YH; Alanazi AS; Alatawi AD; Algarni MA; Almalki ZS; Alahmari AK; Alhassan HH; Mallhi TH
Front Pharmacol; 2024; 15():1370344. PubMed ID: 38898922
[No Abstract] [Full Text] [Related]
7. Sputum microbiota profiles of treatment-naïve TB patients in Uganda before and during first-line therapy.
Kateete DP; Mbabazi MM; Nakazzi F; Katabazi FA; Kigozi E; Ssengooba W; Nakiyingi L; Namiiro S; Okwera A; Joloba ML; Muwonge A
Sci Rep; 2021 Dec; 11(1):24486. PubMed ID: 34966183
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis outcomes in Papua, Indonesia: the relationship with different body mass index characteristics between papuan and non-Papuan ethnic groups.
Kenangalem E; Waramori G; Pontororing GJ; Sandjaja ; Tjitra E; Maguire G; Kelly PM; Anstey NM; Ralph AP
PLoS One; 2013; 8(9):e76077. PubMed ID: 24086690
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis treatment during the COVID-19 pandemic: actions offered and case profile.
Antunes LB; Andrade RLP; Ribeiro RR; Monroe AA; Signor E; Bianchini ASMO; Veira NF; Gonzales RIC
Rev Gaucha Enferm; 2024; 45():e20230127. PubMed ID: 38655930
[TBL] [Abstract][Full Text] [Related]
10. Decentralising DOT for drug-susceptible TB from the health facilities to the community level in Togo.
Dogo FM; Ate S; Agossou K; Menon S; Fiogbé AA; Akpadja K; Adjoh SK; Veronese V; Merle CS; Koura KG
Int J Tuberc Lung Dis; 2024 Apr; 28(4):195-201. PubMed ID: 38563340
[TBL] [Abstract][Full Text] [Related]
11. Sex-based differences in TB treatment compliance: A mediating factor for sputum conversion among newly diagnosed pulmonary TB patients in Chennai, South India.
Krishnamoorthy Y; C S; Govindan D
Heliyon; 2024 May; 10(10):e31185. PubMed ID: 38803852
[TBL] [Abstract][Full Text] [Related]
12. The Titanic question in TB control: Should we worry about the bummock?
Fortune SM
Proc Natl Acad Sci U S A; 2024 Apr; 121(14):e2403321121. PubMed ID: 38527210
[No Abstract] [Full Text] [Related]
13. Risk factors for delayed sputum conversion: A qualitative case study from the person-in-charge of TB program's perspectives.
Wardani DWSR; Pramesona BA; Septiana T; Soemarwoto RAS
J Public Health Res; 2023 Oct; 12(4):22799036231208355. PubMed ID: 37901194
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and factors associated with sputum smear non-conversion after two months of tuberculosis treatment among smear-positive pulmonary tuberculosis patients in Rwanda: a cross-sectional study.
Gatete G; Njunwa KJ; Migambi P; Ntaganira J; Ndagijimana A
BMC Infect Dis; 2023 Jun; 23(1):408. PubMed ID: 37322426
[TBL] [Abstract][Full Text] [Related]
15. The Cavity as a Lasting Abode for Tuberculous Bacilli: An Observational Study.
Jawad N; Jafri S; Saifullah N; Ahmed N
SN Compr Clin Med; 2022; 4(1):40. PubMed ID: 35071986
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Treatment Outcome with Inflammatory Biomarkers after 2 Months of Therapy in Pulmonary Tuberculosis Patients: Preliminary Results.
Stefanescu S; Cocoș R; Turcu-Stiolica A; Shelby ES; Matei M; Subtirelu MS; Meca AD; Stanciulescu EC; Popescu SO; Biciusca V; Pisoschi CG
Pathogens; 2021 Jun; 10(7):. PubMed ID: 34206598
[TBL] [Abstract][Full Text] [Related]
17. Determinants of sputum smear nonconversion in smear-positive pulmonary tuberculosis patients in Suriname, 2010 - 2015.
Commiesie E; Stijnberg D; Marín D; Perez F; Sanchez M
Rev Panam Salud Publica; 2019; 43():e86. PubMed ID: 31892924
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with month 2 smear non-conversion among Category 1 tuberculosis patients in Karachi, Pakistan.
D'Souza KA; Zaidi SMA; Jaswal M; Butt S; Khowaja S; Habib SS; Malik AA
J Infect Public Health; 2018; 11(2):283-285. PubMed ID: 28662884
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.
Mlotshwa M; Abraham N; Beery M; Williams S; Smit S; Uys M; Reddy C; Medina-Marino A
BMC Infect Dis; 2016 Aug; 16():365. PubMed ID: 27484399
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
